This trial will test the feasibility and effects of exercise and VR on motor behavior and neuroplasticity in PD patients. If successful, this could provide new insight into using AE and VR to improve cognition, gait, and neuroplasticity in PD patients.
- Parkinson's Disease
5 Primary · 1 Secondary · Reporting Duration: Baseline to 3 weeks
Side Effects for
1 Treatment Group
Combined Aerobic Exercise (AE) and Virtual Reality (VR)-based program
1 of 1
25 Total Participants · 1 Treatment Group
Primary Treatment: Aerobic Exercise · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 85 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are individuals aged eighty-five or above allowed to participate in this trial?
"This research project is looking for participants aged 18 or older, up to a maximum age of 85." - Anonymous Online Contributor
Is there still an opportunity to join this scientific experiment?
"According to the clinicaltrials.gov website, this study is actively recruiting participants, having been originally posted on November 1st 2022 and updated most recently on that same date." - Anonymous Online Contributor
What are the eligibility criteria for taking part in this research project?
"This clinical trial seeks to enlist 25 individuals with idiopathic Parkinson's Disease, aged between 18 and 85. Candidates must attain a score of 23 or more on the Mini Mental State Examination and present with Hoehn and Yahr stages 1-3 symptoms." - Anonymous Online Contributor
How many participants are actively participating in this clinical trial?
"Affirmative. Per the information on clinicaltrials.gov, this research venture is presently recruiting volunteers. This study was made available to the public on November 1st 2022 and has since been updated once; it seeks 25 participants at a single location." - Anonymous Online Contributor